Review Article
The Significance of Long Noncoding RNA H19 in Predicting Progression and Metastasis of Cancers: A Meta-Analysis
Table 1
Characteristics of studies included in this meta-analysis for H19.
| Author | Year | Country | Tumor type | Sample | Sample size | Cut-off value |
| Zhang [3] | 2014 | China | GC | Tissue | 80 | Mean | Zhang [21] | 2016 | China | NSCLC | Tissue | 70 | Median | Arita [22] | 2013 | Japan | GC | Plasma | 43 | 0.32 | Wang [11] | 2015 | China | RCC | Tissue | 92 | 3.8-fold change | Wang [23] | 2016 | China | GBC | Tissue | 20 | NA | You [24] | 2014 | China | GC | Tissue | 30 | Median | Esteves [25] | 2005 | Brazil | HNSCC | Tissue | 35 | Absence/presence | Huang [26] | 2015 | China | EC | Tissue | 133 | Median | Chen [27] | 2016 | China | GC | Tissue | 128 | Median | Zhu [28] | 2015 | China | OC | Tissue | 70 | NA | Tan [29] | 2016 | China | EC | Tissue | 64 | NA | Wang [30] | 2016 | China | GBC | Tissue | 24 | Median | Han [31] | 2016 | China | CRC | Tissue | 83 | 3.8-fold change |
|
|
GC: gastric cancer, NSCLC: non-small-cell lung cancer, RCC: renal cell carcinoma, GBC: gallbladder cancer, HNSCC: head-and-neck squamous cell carcinomas, EC: esophageal cancer, OC: ovarian cancer, and CRC: colorectal cancer.
|